DLD Asset Management »

United Therapeutics Corporation shares owned by DLD Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.8M 11k 419.02
2025-06-30 $4.1M 14k 287.54

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation